feed,title,long_url,short_url
gNews,SRPT Stock: Why Sarepta Is Expected To Dominate Its Gene Therapy Market | Investor's Business Daily - Investor's Business Daily,https://www.investors.com/research/ibd-stock-of-the-day/srpt-stock-why-sarepta-is-expected-to-dominate-its-gene-therapy-market/,https://bit.ly/3D0Pz97
